The consortium comprises GIC and IK Partners, entering the equity, as well as Keensight Capital and Parquest, reinforcing their existing positions. It will become the new shareholder of Unither Pharmaceuticals alongside the management team... Read... Aenova: strategic investments in new technologies...
Coming to venue;Amsterdamis the largest city inNetherlands, brims with activity day and night. We hope you get to enjoy the countless activities and gastronomic scenes. We hope to have the opportunity to explore the sights, unparalleled history and cuisine of this cosmopolitan capital. ...
17. Changzhou City, Long Life Engineering Limited was founded in 2002, the production of pharmaceutical lactose and other medicinal materials enterprises, with a total investment of 1, 250 million, registered capital of 2 million. 常州市朗生生物工程有限公司创建于2002年,是生产药用乳糖及其它药用辅料的...
Share buyback program Authorized capital Corporate governance Articles of association Shareholders meeting Corporate governance charter Code of Conduct Remuneration policy Reports & presentations Analyst coverage Key financials IPO corner Financial news Regulated information ESG - Sustainability at Azelis Contact ...
trial,run,test- the act of testing something; "in the experimental trials the amount of carbon was measured separately"; "he called each flip of the coin a new trial" phase I,phase I clinical trial- a clinical trial on a few persons to determine the safety of a new drug or invasive ...
is a 100% national capital company. Along its trajectory of more than four decades, Aché has become a dynamic company with strategic partnerships, inside and outside Brazil, for its expertise in similar medicines, management of a mature portfolio, knowledge of the Brazilian consumer market, and...
Figure 1depicts the number of mergers or acquisitions and the average deal size over the period 1990–2011. This chart is based on data from Recombinant Capital. Since 1990, there has been a dramatic upward trend in the number of reported mergers in the pharmaceutical industry, consistent with...
Operating profit of the Ipsen group 2014-2019 Leading global pharmaceutical risers based on market capitalization 2022 U.S. venture investments in infectious disease companies 2006-2023 U.S. number of venture capital deals for infectious disease companies 2006-2023 ...
known as the "Number One Medicine City in the World", New Oriental Pharmaceutical Co., Ltd. has gradually developed and grown from New Oriental Medicinal Materials Company in 2009 to a strong and extensive domestic and international market. With a registered capital of 5 million yuan, it has ...
Barrington James are an industry leading, global recruitment business that exclusively serves the Pharmaceutical, Biotechnology and Medical Device sectors. With offices all over the world and hundreds of specialists dedicated to sourcing exceptional talent, we have the capacity and capabilities to deliver ...